{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T19:58:20Z","timestamp":1792094300736,"version":"4.4.0"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"1","funder":[{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s12879-018-2960-9","type":"journal-article","created":{"date-parts":[[2018,1,26]],"date-time":"2018-01-26T07:07:39Z","timestamp":1516950459000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":83,"title":["Empiric antibiotic therapy in urinary tract infection in patients with risk factors for antibiotic resistance in a German emergency department"],"prefix":"10.1186","volume":"18","author":[{"given":"Sebastian","family":"Bischoff","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Walter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marlis","family":"Gerigk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias","family":"Ebert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5730-1558","authenticated-orcid":false,"given":"Roger","family":"Vogelmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,1,26]]},"reference":[{"key":"2960_CR1","doi-asserted-by":"crossref","unstructured":"Wagenlehner F, Tandogdu Z, Bartoletti R, Cai T, Cek M, Kulchavenya E, Koves B, Naber K, Perepanova T, Tenke P, et al. The global prevalence of infections in urology study: a long-term, worldwide surveillance study on urological infections. Pathogens. 2016;5(1)","DOI":"10.3390\/pathogens5010010"},{"key":"2960_CR2","doi-asserted-by":"crossref","unstructured":"Horcajada JP, Shaw E, Padilla B, Pintado V, Calbo E, Benito N, Gamallo R, Gozalo M, Rodriguez-Bano J, group I et al: Healthcare-associated, community-acquired and hospital-acquired bacteraemic urinary tract infections in hospitalized patients: a prospective multicentre cohort study in the era of antimicrobial resistance. Clin. Microbiol. Infect 2013, 19(10):962-968.","DOI":"10.1111\/1469-0691.12089"},{"issue":"1","key":"2960_CR3","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.ajem.2010.09.030","volume":"30","author":"T Khawcharoenporn","year":"2012","unstructured":"Khawcharoenporn T, Vasoo S, Ward E, Singh K. High rates of quinolone resistance among urinary tract infections in the ED. Am. J. Emerg. Med. 2012;30(1):68\u201374.","journal-title":"Am. J. Emerg. Med"},{"issue":"3","key":"2960_CR4","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1016\/j.ajem.2016.11.021","volume":"35","author":"R Rosa","year":"2017","unstructured":"Rosa R, Abbo LM, Raney K, Tookes HE 3rd, Supino M. Antimicrobial resistance in urinary tract infections at a large urban ED: factors contributing to empiric treatment failure. Am. J. Emerg. Med. 2017;35(3):397\u2013401.","journal-title":"Am. J. Emerg. Med"},{"issue":"24","key":"2960_CR5","doi-asserted-by":"publisher","first-page":"2176","DOI":"10.2146\/ajhp140832","volume":"72","author":"C Zatorski","year":"2015","unstructured":"Zatorski C, Jordan JA, Cosgrove SE, Zocchi M, May L. Comparison of antibiotic susceptibility of Escherichia Coli in urinary isolates from an emergency department with other institutional susceptibility data. Am. J. Health Syst. Pharm. 2015;72(24):2176\u201380.","journal-title":"Am. J. Health Syst. Pharm"},{"issue":"10","key":"2960_CR6","doi-asserted-by":"publisher","first-page":"1473","DOI":"10.1016\/j.ajem.2015.07.047","volume":"33","author":"L Kratochwill","year":"2015","unstructured":"Kratochwill L, Powers M, MA MG, King L, O'Neill JM, Venkat A. Factors associated with ciprofloxacin-resistant Escherichia Coli urinary tract infections in discharged ED patients. Am. J. Emerg. Med. 2015;33(10):1473\u20136.","journal-title":"Am. J. Emerg. Med"},{"issue":"5","key":"2960_CR7","doi-asserted-by":"publisher","first-page":"295","DOI":"10.2310\/8000.2012.120666","volume":"14","author":"L Filiatrault","year":"2012","unstructured":"Filiatrault L, RM MK, Patrick DM, Roscoe DL, Quan G, Brubacher J, Collins KM. Antibiotic resistance in isolates recovered from women with community-acquired urinary tract infections presenting to a tertiary care emergency department. Cjem. 2012;14(5):295\u2013305.","journal-title":"Cjem"},{"issue":"4","key":"2960_CR8","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1007\/s10096-011-1322-y","volume":"31","author":"A Smithson","year":"2012","unstructured":"Smithson A, Chico C, Ramos J, Netto C, Sanchez M, Ruiz J, Porron R, Bastida MT. Prevalence and risk factors for quinolone resistance among Escherichia Coli strains isolated from males with community febrile urinary tract infection. European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology. 2012;31(4):423\u201330.","journal-title":"European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology"},{"issue":"2","key":"2960_CR9","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1007\/s00120-011-2512-z","volume":"50","author":"FM Wagenlehner","year":"2011","unstructured":"Wagenlehner FM, Schmiemann G, Hoyme U, Funfstuck R, Hummers-Pradier E, Kaase M, Kniehl E, Selbach I, Sester U, Vahlensieck W, et al. National S3 guideline on uncomplicated urinary tract infection: recommendations for treatment and management of uncomplicated community-acquired bacterial urinary tract infections in adult patients. Der Urologe Ausg A. 2011;50(2):153\u201369.","journal-title":"Der Urologe Ausg A"},{"issue":"3","key":"2960_CR10","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1111\/j.1469-0691.2011.03570.x","volume":"18","author":"AP Magiorakos","year":"2012","unstructured":"Magiorakos AP, Srinivasan A, Carey RB, Carmeli Y, Falagas ME, Giske CG, Harbarth S, Hindler JF, Kahlmeter G, Olsson-Liljequist B, et al. Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin. Microbiol. Infect. 2012;18(3):268\u201381.","journal-title":"Clin. Microbiol. Infect"},{"issue":"3","key":"2960_CR11","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1007\/s10096-003-1084-2","volume":"23","author":"R Colodner","year":"2004","unstructured":"Colodner R, Rock W, Chazan B, Keller N, Guy N, Sakran W, Raz R. Risk factors for the development of extended-spectrum beta-lactamase-producing bacteria in nonhospitalized patients. Eur. J. Clin. Microbiol. Infect. Dis. 2004;23(3):163\u20137.","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"issue":"2","key":"2960_CR12","first-page":"115","volume":"14","author":"M Vardi","year":"2012","unstructured":"Vardi M, Kochavi T, Denekamp Y, Bitterman H. Risk factors for urinary tract infection caused by Enterobacteriaceae with extended-spectrum beta-lactamase resistance in patients admitted to internal medicine departments. The Israel Medical Association journal : IMAJ. 2012;14(2):115\u20138.","journal-title":"The Israel Medical Association journal : IMAJ"},{"issue":"9","key":"2960_CR13","doi-asserted-by":"publisher","first-page":"1150","DOI":"10.1086\/592250","volume":"47","author":"DA Talan","year":"2008","unstructured":"Talan DA, Krishnadasan A, Abrahamian FM, Stamm WE, Moran GJ, Group EMINS. Prevalence and risk factor analysis of trimethoprim-sulfamethoxazole- and fluoroquinolone-resistant Escherichia Coli infection among emergency department patients with pyelonephritis. Clin. Infect. Dis. 2008;47(9):1150\u20138.","journal-title":"Clin. Infect. Dis"},{"issue":"6","key":"2960_CR14","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1177\/1060028015578259","volume":"49","author":"BA Faine","year":"2015","unstructured":"Faine BA, Harland KK, Porter B, Liang SY, Mohr N. A clinical decision rule identifies risk factors associated with antimicrobial-resistant urinary pathogens in the emergency department: a retrospective validation study. Ann Pharmacother. 2015;49(6):649\u201355.","journal-title":"Ann Pharmacother"},{"issue":"2","key":"2960_CR15","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1128\/JCM.39.2.438-444.2001","volume":"39","author":"A Sotto","year":"2001","unstructured":"Sotto A, De Boever CM, Fabbro-Peray P, Gouby A, Sirot D, Jourdan J. Risk factors for antibiotic-resistant Escherichia Coli isolated from hospitalized patients with urinary tract infections: a prospective study. J Clin Microbiol. 2001;39(2):438\u201344.","journal-title":"J Clin Microbiol"},{"issue":"2","key":"2960_CR16","doi-asserted-by":"publisher","first-page":"164","DOI":"10.2174\/138161213804070320","volume":"19","author":"GO Gutkind","year":"2013","unstructured":"Gutkind GO, Di Conza J, Power P, Radice M. Beta-lactamase-mediated resistance: a biochemical, epidemiological and genetic overview. Curr Pharm Des. 2013;19(2):164\u2013208.","journal-title":"Curr Pharm Des"},{"key":"2960_CR17","doi-asserted-by":"crossref","unstructured":"de With K, Allerberger F, Amann S, Apfalter P, Brodt HR, Eckmanns T, Fellhauer M, Geiss HK, Janata O, Krause R, et al. Strategies to enhance rational use of antibiotics in hospital: a guideline by the German Society for Infectious Diseases. Infection. 2016;","DOI":"10.1007\/s15010-016-0885-z"},{"issue":"8","key":"2960_CR18","doi-asserted-by":"publisher","first-page":"e638","DOI":"10.1016\/j.ijid.2013.01.030","volume":"17","author":"J Lee","year":"2013","unstructured":"Lee J, Oh CE, Choi EH, Lee HJ. The impact of the increased use of piperacillin\/tazobactam on the selection of antibiotic resistance among invasive Escherichia Coli and Klebsiella Pneumoniae isolates. Int. J. Infect. Dis. 2013;17(8):e638\u201343.","journal-title":"Int. J. Infect. Dis"},{"key":"2960_CR19","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1186\/s12879-016-1514-2","volume":"16","author":"S Kundrapu","year":"2016","unstructured":"Kundrapu S, Sunkesula VC, Jury LA, Cadnum JL, Nerandzic MM, Musuuza JS, Sethi AK, Donskey CJ. Do piperacillin\/tazobactam and other antibiotics with inhibitory activity against Clostridium Difficile reduce the risk for acquisition of C. Difficile colonization? BMC Infect Dis. 2016;16:159.","journal-title":"BMC Infect Dis"},{"issue":"5","key":"2960_CR20","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1016\/j.ijantimicag.2015.08.011","volume":"46","author":"K Bush","year":"2015","unstructured":"Bush K. A resurgence of beta-lactamase inhibitor combinations effective against multidrug-resistant gram-negative pathogens. Int J Antimicrob Agents. 2015;46(5):483\u201393.","journal-title":"Int J Antimicrob Agents"},{"issue":"7","key":"2960_CR21","doi-asserted-by":"publisher","first-page":"4355","DOI":"10.1128\/AAC.00405-16","volume":"60","author":"HS Sader","year":"2016","unstructured":"Sader HS, Castanheira M, Flamm RK, Jones RN. Antimicrobial activities of Ceftazidime-Avibactam and comparator agents against gram-negative organisms isolated from patients with urinary tract infections in U.S. medical centers, 2012 to 2014. Antimicrob Agents Chemother. 2016;60(7):4355\u201360.","journal-title":"Antimicrob Agents Chemother"},{"issue":"3","key":"2960_CR22","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/j.diagmicrobio.2014.07.005","volume":"80","author":"RK Flamm","year":"2014","unstructured":"Flamm RK, Sader HS, Farrell DJ, Jones RN. Ceftazidime-avibactam and comparator agents tested against urinary tract isolates from a global surveillance program (2011). Diagnostic microbiology and infectious disease. 2014;80(3):233\u20138.","journal-title":"Diagnostic microbiology and infectious disease"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-018-2960-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,9]],"date-time":"2019-10-09T17:15:38Z","timestamp":1570641338000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-018-2960-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1,26]]},"references-count":22,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["2960"],"URL":"https:\/\/doi.org\/10.1186\/s12879-018-2960-9","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,1,26]]},"assertion":[{"value":"2 May 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 January 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 January 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study is in accordance with the Declaration of Helsinki and has been approved by the local ethics committee of the Medical Faculty of Mannheim, University of Heidelberg (ref# 2014-549\u00a0N-MA). The study was a retrospective analysis of a de-identified database and did not involve any new studies of human or animal subjects performed by any of the authors.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Data were collected by chart review. The local ethics committee waived the necessity for individual informed consent.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Roger Vogelmann, Sebastian Bischoff, Thomas Walter, Marlis Gerigk and Matthias Ebert declare that they have no conflict of interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"56"}}